
The price history is unavailable right now.
| 1W | 1M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|
| Stock | - | - | - | - | - |
| SPY | - | - | - | - | - |
Historical total returns · Dividends reinvested
Nothing in its numbers stands out right now.
No weak spot in its numbers right now.
Loading…
In 1 copy portfolio. See which with Premium
No company summary is available right now.
Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035Yahoo Finance · 6 h ago
Can Regeneron Stock Hit $1,400?trefis.com · 7 h ago
Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech?The Motley Fool · 3 d ago
REGN Soars 27.4% in a Month: Buy, Sell or Hold the Stock?Yahoo Finance · 5 d ago
Regeneron Pharmaceuticals (REGN) Reports Early MASLD Trial Data With 62% Liver Fat NormalizationYahoo Finance · 6 d ago